Zakrowski Donald A's Form 4 filing
Eli Lilly & Co (LLY) · filed Mar 11, 2024
- Accession no.
- 0000059478-24-000082
- Filed
- Mar 11, 2024
- Trade date
- Feb 12-Mar 11, 2024
- Filing delay
- 28 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 2 derivative transactions. Open-market sales total $565.2K. It was filed 28 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Zakrowski Donald ACIK 0001561539 | Officer (SVP, Finance, & CAO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 | Common Stock | SSaleDisposed | −750 | $753.60 | −$565,200 | 7,880 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | Common Stock | AGrant or awardAcquired | +184 | $0.00 | $0 | 184 | Direct | |
| Feb 12, 2024 | Common Stock | AGrant or awardAcquired | +186 | $0.00 | $0 | 186 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.